2 Drug Stocks Near Key Technical Levels After ASCO

PBYI and TGTX stocks are both trading near key Fibonacci levels

Jun 5, 2017 at 2:45 PM
facebook X logo linkedin

Biotech stocks Puma Biotechnology Inc (NASDAQ:PBYI) and TG Therapeutics Inc (NASDAQ:TGTX) have had big years, both sporting 2017 gains of more than 180%. Like sector peer Loxo Oncology Inc (NASDAQ:LOXO), PBYI and TGTX are making waves again today, too, following this weekend's American Society of Clinical Oncology (ASCO) annual event. Plus, both stocks are testing key technical levels. 

PBYI Stock Could Have More Upside

Puma stock was last seen 3.7% higher at $84.95, and earlier hit an annual high of $92, after the company presented upbeat data on its cancer drug, neratinib. This has PBYI shares comfortably above the $80-$81 region, which is not only home to their recent highs, but also represents a 23.6% Fibonacci retracement of a decline from the 2014 peak to the 2016 bottom. 

puma biotech

Elsewhere, analysts are mostly bullish on PBYI stock, with four out of five rating it a "strong buy." Plus, even with their recent surge, the shares remain below their average 12-month price target of $89.43. Not everyone's bullish, however. About 8.3 million shares of Puma Biotechnology are controlled by short sellers, which is equal to seven times the stock's average daily trading pace. More gains could ensue if these bears start to throw in the towel. 

The Level to Watch for TGTX Stock

Meanwhile, TG Therapeutics stock jumped out of the gate, but was last seen 5.8% lower at $13.05, as investors consider an update on a combination therapy using its leukemia drug. In fact, the shares earlier hit an annual high of $15.35. The $13.80 area could now be one to watch, as this represents a 61.8% Fibonacci retracement of TGTX's rally from early 2014 to its 2015 peak. 

tgtx stock

Like PBYI, analysts are very bullish on TG Therapeutics, with all seven covering brokerages rating it a "strong buy." Moreover, the shares' consensus 12-month price target stands all the way up at $24.14 -- territory not charted since early 2012. But short interest is extremely elevated, as it would take these bears 12 sessions to cover their positions, based on average daily volumes. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI